SAN FRANCISCO, Aug. 06, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended June 30, 2026. Second Quarter 2026 Financial Highlights Revenue of $224.2 million, a 20.1% increase compared to second quarter 2025 Gross margin of 72.8%, a 160-basis point increase compared to second quarter 2025 Net loss of $0.4 million, a $13.8 million improvement compared to second quarter 2025 Adjusted EBITDA and adjusted EBITDA margin of $43.3 million and 19.3%, respectively, a $27.6 million and 1,090-basis point improvement, respectively, compared to second quarter 2025 Unrestricted cash, cash equivalents, and marketable securities of $591.3 million as of June 30, 2026 Increased fiscal year 2026 revenue guidance to $880 million to $890 million and adjusted EBITDA margin guidance to 13.0% to 14.0% Recent Operational Highlights Delivered another strong quarter, demonstrated by robust volume led revenue growth and expanded margins, with continued momentum across cardiology, primary care, innovative channels, and international markets Entered into a definitive agreement to acquire Vital Connect, Inc. ("VitalConnect"), a privately held company that offers complementary ambulatory cardiac monitoring technology, for total consideration of approximately $287.5 million.
